Delizia Pharmaceutical Private Limited

Delizia Pharmaceutical Private Limited - pharma in Nallasopara, Maharashtra, India. FY 2026 financials & compliance.
CIN U52300MH2014PTC252110 Incorporated 15 January 2014 ROC Mumbai HQ Nallasopara, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹51.04 Lakh
▼ 17.11% YoY
Net profit · FY 2025
₹22,117
Net margin 0.4%
EBITDA · FY 2025
₹6.16 Lakh
EBITDA margin 12.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings

About Delizia Pharmaceutical Private Limited

Data last updated:

Delizia Pharmaceutical Private Limited is a private limited company based in Nallasopara, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 January 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52300MH2014PTC252110. Its GSTIN is 27AAECD9226G1ZL (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ganesh Bholanath Chaurasia and Savita Sandip Chaurasiya.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 03 A Wing Ground Floor Max Avenue Ostwal Nagari Village More, Nallasopara, Maharashtra, India – 401209.

As per the financials filed for FY 2025, the company reported a revenue of ₹51.04 Lakh. For the same year it recorded a net profit of ₹22,117 (net margin 0.4%) and EBITDA of ₹6.16 Lakh (EBITDA margin 12.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 5% over five years.

As per MCA filings, the company has open charges of ₹10 Lakh on record.

Delizia Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0039370). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U52300MH2014PTC252110
Registration Number 252110
Incorporation Date 15 January 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0039370

Recognitions & Rankings of Delizia Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-17-0039370

Contact details

Delizia Pharmaceutical Private Limited's registered office is in Nallasopara, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No. 03 A Wing Ground Floor Max Avenue Ostwal Nagari Village More, Nallasopara, Maharashtra, India – 401209
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Delizia Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Delizia Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Delizia Pharmaceutical is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Delizia Pharmaceutical Private Limited, buy the company report.

Financials of Delizia Pharmaceutical Private Limited

FY 2024 filings available

Delizia Pharmaceutical Private Limited reported revenue of ₹51.04 Lakh for FY 2025.

Revenue · FY 2025
₹51.04 Lakh
Net profit · FY 2025
₹22,117 margin 0.4%
EBITDA · FY 2025
₹6.16 Lakh margin 12.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 7%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 121%
3 years · compounded
▼ 15%
5 years · compounded
▼ 5%

Revenue has declined at a compounded annual rate (CAGR) of 5% over five years. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.16 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22,117
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.1%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Delizia Pharmaceutical Private Limited, buy the company report.

Board of directors of Delizia Pharmaceutical Private Limited

Delizia Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ganesh Bholanath ChaurasiaDirector15 Jan 201412 Years 9 MonthsCurrent
Savita Sandip ChaurasiyaDirector15 Jan 201412 Years 9 MonthsCurrent

Auditor

Delizia Pharmaceutical Private Limited is audited by BHIKHUBHAI H SHAH & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
BHIKHUBHAI H SHAH & CO.FY 2023049268

Shareholding

The shareholding of Delizia Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Delizia Pharmaceutical Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Jun 2018100190843Others₹10 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Delizia Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Delizia Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECD9226G1ZLMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Delizia Pharmaceutical Private Limited, buy the company report.

Recent activity

Delizia Pharmaceutical Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Ganesh Bholanath Chaurasia was appointed as Director on 15 Jan 2014.

AGM
Delizia Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Delizia Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100190843 was registered on 07 Jun 2018.
Appointed
Ganesh Bholanath Chaurasia was appointed as Director.
Appointed
Savita Sandip Chaurasiya was appointed as Director.
Incorporation
15 Jan 2014
Delizia Pharmaceutical Private Limited was registered on 15 Jan 2014 with Roc Mumbai & aged 12 years 9 months as per MCA records.

Frequently asked questions

Delizia Pharmaceutical is an active private limited company based in Nallasopara, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 January 2014 (12+ years old) and is registered under CIN U52300MH2014PTC252110.

Delizia Pharmaceutical has 2 current directors:

The latest financial statements of Delizia Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Delizia Pharmaceutical is 27AAECD9226G1ZL, registered in Maharashtra.

The CIN (Corporate Identification Number) of Delizia Pharmaceutical is U52300MH2014PTC252110. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Delizia Pharmaceutical was incorporated on 15 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

Ganesh Bholanath Chaurasia was appointed as Director on 15 Jan 2014. Savita Sandip Chaurasiya was appointed as Director on 15 Jan 2014.

Yes, Delizia Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0039370).

The registered office of Delizia Pharmaceutical is at Shop No. 03 A Wing Ground Floor Max Avenue Ostwal Nagari Village More, Nallasopara, Maharashtra, India – 401209.

Delizia Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.